AASLD

Study Finds 3 in 4 Overweight, Obese Adults Have Steatotic Liver Disease MASH

As much as 75% of overweight and obese individuals have steatotic liver disease, according to results of a recent ...

FEBRUARY 11, 2025

Shortened Protocol Can Prevent Infection in Recipients of HCV+ Organs

A shortened antiviral protocol adding ezetimibe can prevent infection in solid-organ recipients who receive ...

JULY 31, 2024

Loren Laine, MD, on DDW Sessions You Can’t Miss

Digestive Disease Week 2024 is just around the corner, this year being held in Washington, D.C. 

MAY 15, 2024

New AASLD Practice Guidance on MASLD

The American Association for the Study of Liver Diseases released an updated practice guidance on metabolic ...

MARCH 11, 2024

Societies Change Term for Fatty Liver To Focus on Steatosis

After years of discussion and review, an international working group has announced recently that they will refer to ...

AUGUST 28, 2023

DDW Liver Disease Programming Preview With Grace Su, MD

Grace Su, MD, previews some highlights of AASLD’s DDW 2023 programming.

MAY 1, 2023

Multidisciplinary Program for Fatty Liver Disease Helps Patients Lose Weight

WASHINGTON—A multidisciplinary program for fatty liver disease can enable more referrals for bariatric ...

NOVEMBER 10, 2022

A Registry for Rare Pediatric Hepatitis Cases

NASPGHAN and AASLD have joined together to create a registry of rare pediatric hepatitis cases.

JULY 22, 2022

QI Project Aims to Reduce Variability in Varices Care

Adherence to published surveillance guidelines for esophageal varices in patients with cirrhosis can be bolstered ...

MAY 20, 2021

Biomarker Panel May Help Predict Kidney Damage in Patients With Alcoholic Hepatitis

One of the first studies of its kind has concluded that interleukin-18 (IL-18) appears to be a specific biomarker ...

MAY 13, 2021

New Triple-Antigen Vaccine For Hep B Could Become Standard In Some Patient Groups

A new triple-antigen vaccine against infection with the hepatitis B virus confers greater protection than the ...

MAY 13, 2021

FMT Linked to Gains in Liver Function in Cirrhotic Patients

A single fecal microbiota transplant is safe, improves liver function and reduces pro-inflammatory cytokines in ...

MAY 12, 2021

Load more